WilliamPhilipWerschlerMD

Dermatology • Spokane, WA

Dermatologic Surgery

Physician

Join to view full profile

Dr. Werschler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Werschler's full profile

Already have an account?

Office
104 W 5th Ave
# 330W
Spokane, WA 99204
Phone+1 509-624-1184

Fax+1 509-625-1449

Education & Training

George Washington University School of MedicineResidency, Dermatology, 1986 - 1989
University of Arizona College of Medicine-TucsonInternship, Internal Medicine, 1985 - 1986
George Washington University School of Medicine and Health SciencesClass of 1985

Certifications & Licensure

AZ State Medical License 2005 - 2026
HI State Medical License 2005 - 2026
ID State Medical License 2007 - 2026
IL State Medical License 2008 - 2026
WA State Medical License 1989 - 2026
CA State Medical License 2006 - 2025
CO State Medical License 2007 - 2025
NV State Medical License 2006 - 2025
DC State Medical License 1987 - 2024
MI State Medical License 2008 - 2024
NY State Medical License 2005 - 2021
American Board of Dermatology Dermatology
National Board of Physicians and Surgeons Dermatology
Join now to see all

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) Start of enrollment: 2010 Sep 01
Completed
Phase 3
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 May 01
Completed
Phase 3
Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis Start of enrollment: 2013 Feb 01
Completed
Phase 2
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
Completed
Phase 3
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2014 Apr 01
Completed
Phase 2
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris Start of enrollment: 2014 Sep 01
Completed
Not Applicable
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris Start of enrollment: 2015 Apr 01
Completed
Phase 2
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
Completed
Phase 3
Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Papulopustular Rosacea in Elderly Patients: Post-hoc Analysis of Results from Two Randomized, P...
Lawrence J Green, Hilary Baldwin, Jeffrey Sugarman, Bill Andriopoulos, Ori Nov
The Journal of Clinical and Aesthetic Dermatology. 2024-10-01
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.
Leon H Kircik, Linda Stein Gold, Michael Gold, Jonathan S Weiss, Julie C Harper
Dermatology and Therapy. 2024-05-01
4 citations
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
Linda Stein Gold, Edward Lain, James Q Del Rosso, Michael Gold, Zoe D Draelos
Journal of the American Academy of Dermatology. 2023-11-01

Journal Articles

Glycopyrronium Tosylate in Pediatric Primary Axillary Hyperhidrosis: Post Hoc Analysis of Efficacy and Safety Findings by Age from Two Phase Three Randomized Controlle...
Douglass W Forsha, David M Pariser, Adelaide A Hebert, Dee Anna Glaser, William P Werschler, Pediatric Dermatology

Press Mentions

Lung Drug Proved to Ease the Pain of Psoriasis Is Providing Relieve for Three Quarters of PatientsMay 1st, 2023
Dermcast.tv Dermatology PodcastsMarch 24th, 2016